What happens during a multi-day water fast, and is it safe?
It may lower weight and blood pressure within days, but about two-thirds of weight lost is lean mass, benefits fade, and it needs medical supervision.
A multi-day water fast means drinking only water for several days. Within days the body burns fat for fuel and makes ketones, weight drops and blood pressure falls. But roughly two-thirds of the weight lost is lean mass rather than fat, and in trials the metabolic benefits were gone 3 to 4 months later1. Supervised clinic data suggest serious problems are uncommon2, yet it is not safe for everyone.
What you can do
- Try a gentler pattern first, such as a daily eating window, before considering anything longer than a day or two.
- If you still want a multi-day fast, get a doctor's go-ahead and arrange supervision. In 768 supervised water-only fasts, 2 visits had a serious adverse event2.
- End a long fast slowly: restart with small, low-calorie meals over several days to lower the risk of refeeding syndrome8.
Be careful if
- Do not fast if pregnant, breastfeeding, underweight, under 18 or with eating-disorder history: fasting linked to worse symptoms11, pregnancy data are thin12; type 1 diabetes needs specialist advice.
- Medicines: insulin and sulfonylureas raise the risk of low blood sugar when fasting10, and blood-pressure drugs often need dose changes4. Do not adjust them on your own.
- Never go without fluids ('dry fasting'): going without water for more than a few days is fatal, and even modest deficits harm children, frail older adults and unwell people9.
Go deeper
How it works What it does in your body, in plain words 2 min
The first days. The body first uses up stored carbohydrate. As insulin falls, fat is broken down and the liver makes ketones, which the brain can use as fuel1. In a clinic study of 1,422 people fasting 4 to 21 days on about 200 to 250 kcal a day (a modified fast, not water alone), blood sugar fell to the low-normal range and ketones rose in every group, and 93% reported no hunger3.
Weight and lean mass. Reviews of human trials report 2% to 10% weight loss over 5 to 20 days, but about two-thirds is lean mass, which can include water as well as muscle, and the authors flag possible muscle breakdown as a concern1.
Blood pressure. Pressure consistently falls1. In 1,610 people fasting about 10 days, average blood pressure fell from 126/81 to 120/78 mm Hg and by about 17/9 mm Hg in people with untreated hypertension. Among those taking blood-pressure drugs, medication was stopped in 24% and reduced in 44%. That is why supervision matters4.
Blood sugar and diabetes. Fasting lowered glucose and insulin in adults with normal blood sugar, but not in people with diabetes1. In a pilot trial in type 2 diabetes (32 completers), a one-week 300 kcal-a-day fast brought more weight loss (3.5 vs 2.0 kg) and lower blood pressure at 4 months than usual care, with no significant change in HbA1c5.
It does not last. Three to four months after fasting, the metabolic gains had disappeared even when weight loss was kept1. A 5-day modified fast in 64 healthy adults improved some markers briefly, but gut-microbiome and blood-metabolome differences were gone a month later6. By contrast, two years of moderate calorie restriction in the CALERIE trial improved LDL cholesterol, blood pressure and insulin sensitivity throughout7.
Safety. In a review of 768 supervised water-only fasts, most adverse events were mild and expected, though 212 fasts included at least one severe-graded event and 2 had a serious adverse event2. Headaches, insomnia, hunger and metabolic acidosis show up in some studies1.
Refeeding. Restarting food after prolonged starvation can cause dangerous shifts in phosphate, potassium, magnesium and fluids. It is best documented in malnourished patients, who restart with few calories and thiamine8.
Dry fasting. Going without fluids as well as food is a different and far riskier thing. Going more than a few days without water is fatal9, and our PubMed search found no controlled trials of multi-day dry fasts.
For gentler options see Does limiting your eating window help?, Who should avoid intermittent fasting and Electrolytes beyond water.
The evidence The studies, what they found, and how much to trust them 4 min · 12 sources
Narrative review of human trials. The 2024 review summarized prolonged fasting of 5 to 20 days: ketones rose sharply, weight fell 2% to 10% (about two-thirds lean mass, one-third fat), and blood pressure consistently decreased. Lipid effects were unclear. Fasting glucose, insulin, insulin resistance and HbA1c improved in normoglycemic adults but stayed unchanged in type 1 or type 2 diabetes. Three to four months after the fast, all metabolic benefits were no longer seen, even where weight loss was maintained. Adverse events included metabolic acidosis, headaches, insomnia and hunger; the authors call prolonged fasting "moderately safe"1.
Chart review of supervised water-only fasts. From 2,539 charts at a residential medical facility (2006 to 2011), 768 visits involved adults fasting at least two days on water alone and refeeding for half as long. The highest-grade event was grade 2 or lower in 555 visits, grade 3 in 212 (28%), and grade 4 in 1; there were no grade 5 events and 2 visits had a serious adverse event. Of all adverse events, 75% (4,490) were mild and known reactions to fasting2. This is a retrospective review of people who chose fasting at one center.
Clinic cohorts. The 1,422-person study ran for one year at a specialized clinic using Buchinger fasting (200 to 250 kcal a day) for 4 to 21 days with a lifestyle program. Weight, abdominal circumference and blood pressure fell; glucose dropped to the low-normal range; ketones rose; 93.2% reported no hunger; of 404 people with existing complaints, 341 (84.4%) reported improvement; adverse effects occurred in under 1%3. In 1,610 fasters (4 to 41 days, mean 10, about 250 kcal a day), 920 were normotensive, 313 hypertensive without medication and 377 hypertensive on medication. Pressure fell by 3.0/1.9 mm Hg in normotensive people, 16.7/8.8 in untreated hypertensive people and 7.3/4.7 on average in the medicated group, while 69 women with low blood pressure (under 100/60) saw it rise by 6.3/2.24. These are uncontrolled before-and-after designs.
Randomized trials. In the type 2 diabetes pilot, 46 people on oral drugs and/or insulin were randomized to a 7-day Buchinger fast (300 kcal a day, then gradual refeeding) or usual care; 32 finished. There were no serious adverse events. At 4 months weight fell 3.5 kg versus 2.0 kg (P = 0.03), and systolic and diastolic blood pressure fell significantly, while HbA1c, insulin and HOMA did not improve significantly5. In 64 healthy adults randomized to a 5-day ketogenic modified fast (about 600 kcal a day) or usual eating, weight, glucose and well-being improved, blood pressure fell significantly only after food was reintroduced, and microbiome and metabolome differences were no longer significant one month later6.
The calorie-restriction benchmark. CALERIE randomized 218 healthy, non-obese adults to 25% calorie restriction or usual eating. They achieved about 12% restriction and sustained a 7.5 kg loss (71% fat), with lasting improvements in LDL cholesterol, total-to-HDL ratio, blood pressure, C-reactive protein and insulin sensitivity over two years7. Fasts, in contrast, bring faster changes that tend to fade.
Harms and gaps. Refeeding syndrome features low phosphate, magnesium and potassium and vitamin deficiency; most data come from case reports and observational studies of malnourished patients, with low-energy restarts and thiamine as the standard prevention8. In type 2 diabetes treated with insulin or sulfonylureas, fasting regimens carry an increased risk of low blood sugar10. Intermittent fasting was prospectively associated with higher eating-disorder psychopathology in 491 adults, though selection may play a role11. For pregnancy, only daylight Ramadan fasting has been studied: birth weight was unaffected across 22 studies, but data on other outcomes were insufficient12. Water deprivation beyond a few days is fatal, and modest deficits harm vulnerable groups9.
Conflicting and missing evidence. The clinic cohorts report big improvements, but there is no control group and participants chose to fast. The small randomized trials used modified fasts rather than water alone and measured outcomes within months. None of the trials above measured heart attacks, new diabetes or survival.
Bottom line (confidence 2 of 5). A multi-day water fast may lower weight and blood pressure within days, but much of the weight lost is lean tissue, benefits fade within months, and risks (refeeding, medication problems, dehydration, eating-disorder relapse) are real. If you are curious, choose gentler patterns first and involve a clinician for anything beyond a day or two.
Sources
- Efficacy and safety of prolonged water fasting: a narrative review of human trials. Ezpeleta M, Cienfuegos S, Lin S, et al.. Nutr Rev, 2024. PubMed 37377031
- Is fasting safe? A chart review of adverse events during medically supervised, water-only fasting. Finnell JS, Saul BC, Goldhamer AC, et al.. BMC Complement Altern Med, 2018. PubMed 29458369
- Safety, health improvement and well-being during a 4 to 21-day fasting period in an observational study including 1422 subjects. Wilhelmi de Toledo F, Grundler F, Bergouignan A, et al.. PLoS One, 2019. PubMed 30601864
- Blood Pressure Changes in 1610 Subjects With and Without Antihypertensive Medication During Long-Term Fasting. Grundler F, Mesnage R, Michalsen A, et al.. J Am Heart Assoc, 2020. PubMed 33222606
- Effects of A One-week Fasting Therapy in Patients with Type-2 Diabetes Mellitus and Metabolic Syndrome - A Randomized Controlled Explorative Study. Li C, Sadraie B, Steckhan N, et al.. Exp Clin Endocrinol Diabetes, 2017. PubMed 28407662
- Health benefits of a five-day at-home modified fasting program: a randomised controlled trial. Grundler F, Ducarmon QR, Holley A, et al.. Genome Med, 2026. PubMed 42226305
- 2 years of calorie restriction and cardiometabolic risk (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial. Kraus WE, Bhapkar M, Huffman KM, et al.. Lancet Diabetes Endocrinol, 2019. PubMed 31303390
- Refeeding syndrome in the gastroenterology practice: how concerned should we be?. Nunes G, Brito M, Santos CA, et al.. Eur J Gastroenterol Hepatol, 2018. PubMed 29994872
- Hydration, morbidity, and mortality in vulnerable populations. Maughan RJ. Nutr Rev, 2012. PubMed 23121352
- Intermittent fasting and 'metabolic switch': Effects on metabolic syndrome, prediabetes and type 2 diabetes. Rajpal A, Ismail-Beigi F. Diabetes Obes Metab, 2020. PubMed 32372521
- Engagement in Intermittent Fasting is Prospectively Associated With Higher Body Mass Index, Higher Eating Disorder Psychopathology, and Lower Intuitive Eating in Chinese Adults. He J, Chen X, Cui T, et al.. Int J Eat Disord, 2025. PubMed 39530408
- The effect of Ramadan fasting during pregnancy on perinatal outcomes: a systematic review and meta-analysis. Glazier JD, Hayes DJL, Hussain S, et al.. BMC Pregnancy Childbirth, 2018. PubMed 30359228